Gaudium IVF and Women Health Latest Share Price (GAUDIUMIVF)
TODAY IN ONE LINE
With a market cap of ₹934.58 Cr., it trades at a P/E of 38.99. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Gaudium IVF and Women Health flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 56.2% and Profit up 53.7%
- ●High Capital EfficiencyROCE of 48.6% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 16.1%
- ●Healthy Operating MarginsOPM is structurally strong at 34.2%
- ●High Promoter HoldingPromoters hold 71.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.15x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Gaudium IVF and Women Health News
What changed recently?
Recent events, corporate actions, and announcements.
Gaudium IVF and Women Health Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Gaudium IVF and Women Health Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Gaudium IVF and Women Health Ltd trades at a P/E of 38.99× and P/B of 6.26×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Gaudium IVF and Women Health Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Gaudium IVF and Women Health Ltd — derived from the latest tape, not yesterday's close.
Gaudium IVF and Women Health Ltd last traded at ₹128.17 with an intraday range of ₹123.1–₹129.6 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹128.17| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 143.81 | +15.64 | +12.21% |
| R3 | 137.31 | +9.14 | +7.13% |
| R2 | 133.46 | +5.29 | +4.12% |
| R1 | 130.81 | +2.64 | +2.06% |
| PIVOT | 126.96 | -1.21 | -0.95% |
| CURRENT | 128.17 | — | — |
| S1 | 124.31 | -3.86 | -3.01% |
| S2 | 120.46 | -7.71 | -6.02% |
| S3 | 117.81 | -10.36 | -8.08% |
| S4 | 111.31 | -16.86 | -13.15% |
GAUDIUMIVF is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Inside opening range
Gaudium IVF and Women Health Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Gaudium IVF and Women Health Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Gaudium IVF and Women Health Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹934.58 Cr. and reported EPS of ₹3.12.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 104 |
| Other Income | — | 1 |
| Total Income | — | 105 |
| — | 34 | |
| Gross ProfitDerived | — | 71 |
| Gross Margin %Derived | — | 67.80% |
| — | 33 | |
| EBITDA (Operating Profit)Derived | — | 38 |
| OPM %Derived | — | 36.13% |
| — | 6 | |
| Profit Before Tax (PBT) | — | 32 |
| — | 8 | |
| Effective Tax %Derived | — | 23.94% |
| Profit/Loss from Discontinued Ops | — | -0 |
| Total Profit for Period | — | 24 |
| Net Profit (Owner's PAT)Derived | — | 24 |
| Net Profit Margin %Derived | — | 23.47% |
| Earnings Per Share (EPS ₹) | — | 3.36 |
| Diluted Shares Outstanding (Cr) | — | 7 |
| Other Comprehensive Income (Net of Tax) | — | 0 |
| Total Expenses (incl. D&A & Interest) | — | 73 |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | — | 7.65% |
| Other Cost % of RevenueDerived | — | 24.02% |
| Interest Coverage (x)Derived | — | 10.07x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 104 | |
| Other Income | 1 | |
| Total Income | 105 | |
34 | ||
| Gross ProfitDerived | 71 | |
| Gross Margin %Derived | 67.80% | |
33 | ||
| EBITDA (Operating Profit)Derived | 38 | |
| OPM %Derived | 36.13% | |
6 | ||
| Profit Before Tax (PBT) | 32 | |
8 | ||
| Effective Tax %Derived | 23.94% | |
| Profit/Loss from Discontinued Ops | -0 | |
| Total Profit for Period | 24 | |
| Net Profit (Owner's PAT)Derived | 24 | |
| Net Profit Margin %Derived | 23.47% | |
| Earnings Per Share (EPS ₹) | 3.36 | |
| Diluted Shares Outstanding (Cr) | 7 | |
| Other Comprehensive Income (Net of Tax) | 0 | |
| Total Expenses (incl. D&A & Interest) | 73 | |
| Material Cost % of RevenueDerived | — | |
| Employee Cost % of RevenueDerived | 7.65% | |
| Other Cost % of RevenueDerived | 24.02% | |
| Interest Coverage (x)Derived | 10.07x |
Gaudium IVF and Women Health segment analysis : revenue and profit mix.
Disclosed business segments at Gaudium IVF and Women Health with their share of revenue and profit, switchable between consolidated and standalone reporting.
Gaudium IVF and Women Health discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Gaudium IVF and Women Health Ltd.
Our AI distills the core fundamental drivers supporting Gaudium IVF and Women Health Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 51 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Gaudium IVF and Women Health Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Gaudium IVF and Women Health Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Gaudium IVF and Women Health Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Gaudium IVF and Women Health Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Gaudium IVF and Women Health Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Gaudium IVF and Women Health Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Gaudium IVF and Women Health Ltd stood at 42.9% of traded volume, against a 20-day average of 40.7%.
Gaudium IVF and Women Health announcements: results, concalls, ratings, M&A.
Filings Gaudium IVF and Women Health sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Gaudium IVF and Women Health files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 24 documents below.
Press Release
Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated July 16, 2026, titled "India's First Listed IVF…
Commencement of commercial production/operations
Gaudium IVF and Women Health Limited has informed the Exchange about Commencement of commercial operations at Company s new IVF Centre/Hub at South…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Gaudium IVF and Women Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the…
Trading Window
Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Outcome of Board Meeting
Gaudium IVF and Women Health Limited has informed the Exchange regarding Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital…
Investor decks & rating reports.
Gaudium IVF and Women Health dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Gaudium IVF and Women Health has declared, sequenced by announce and record date.
Gaudium IVF and Women Health corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Gaudium IVF and Women Health Ltd: business, sector, key facts.
What Gaudium IVF and Women Health Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Gaudium IVF and Women Health Ltd is a listed Indian equity, listed as NSE: GAUDIUMIVF, BSE: 544709.
Gaudium IVF and Women Health Ltd
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Top Gainers TodayScreener
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Gaudium IVF and Women Health Ltd (GAUDIUMIVF).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?
The current share price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) is ₹128.17. Today, the stock has gained by ₹3.78 (3.04%), trading in a range of ₹123.10 to ₹129.60. The stock opened at ₹127.48 with a trading volume of 11,50,597 shares.
02Is Gaudium IVF and Women Health Ltd stock a good investment for long-term?
Gaudium IVF and Women Health Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹934.58 Cr., P/E ratio of 38.99, ROE of 16.08%, and ROCE of 48.6%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Gaudium IVF and Women Health Ltd stock?
The 52-week high price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) is ₹133.00, while the 52-week low is ₹69.18. Currently trading at ₹128.17, the stock is 85.27% above its 52-week low and 3.63% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Gaudium IVF and Women Health Ltd stock at the current price?
Whether to buy Gaudium IVF and Women Health Ltd stock at ₹128.17 depends on multiple factors. The stock is currently trading with a P/E ratio of 38.99 and P/B ratio of 6.26. Today's performance shows a gain of 3.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Gaudium IVF and Women Health Ltd and when is the next dividend?
Gaudium IVF and Women Health Ltd offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹128.17, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd's key financial metrics include: P/E Ratio: 38.99, P/B Ratio: 6.26, ROE: 16.08%, ROCE: 48.6%, Dividend Yield: 0%, EPS: ₹3.12, Book Value: ₹0.00, and Debt-to-Equity: 0.15. The company's market cap stands at ₹934.58 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Gaudium IVF and Women Health Ltd stock performing today in the market?
Gaudium IVF and Women Health Ltd stock opened at ₹127.48 and is currently trading at ₹128.17, showing a gain of ₹3.78 (3.04%). The intraday high is ₹129.60 and low is ₹123.10. The trading volume stands at 11,50,597 shares, indicating strong market participation today.
08What is the P/E ratio of Gaudium IVF and Women Health Ltd and what does it indicate?
Gaudium IVF and Women Health Ltd has a Price-to-Earnings (P/E) ratio of 38.99, which means investors are willing to pay 38.99 for every ₹1 of earnings. With an EPS of ₹3.12, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Gaudium IVF and Women Health Ltd (GAUDIUMIVF) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.